medigraphic.com
ISSN 1870-2821 (Print)
Organo Oficial de la Asociación Mexicana de Mastología

2021, Number 1

<< Back Next >>

Rev Mex Mastol 2021; 11 (1)

Severe acute respiratory syndrome coronavirus 2, a virus that is here to stay

Aguilar BES, Gómez PR, Espinosa RJ, Correa BJ, García MJ

Language: Spanish
References: 41
Page: 9-17
PDF size: 324.26 Kb.


ABSTRACT

Coronaviruses are viruses that mainly affect animals; in different circumstances they can affect humans, as did the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) viruses. These viruses caused an epidemiological alert, without triggering a pandemic; because they have characteristics that make them less efficient in human-to-human infection. However, the Severe Acute Respiratory Syndrome virus 2 (SARS-CoV-2), in addition to overcoming the species barrier, has proven to be efficient in human-to-human transmission, its incubation time is four to 14 days, and some people are asymptomatic, allowing further spread. Due to the previous characteristics, the SARS-CoV-2 is causing a pandemic with a number of deaths greater than that caused by influenza in 1957 and 1968. Mitigating the current pandemic is a challenge for public health and the protection measures remain the same as those disclosed in the 1918 pandemic (before antibiotics and antivirals). This work describes the background of the origin and characteristics of SARS-CoV-2, a virus that is here to stay.


REFERENCES

  1. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011; 81: 85-164.

  2. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966; 121: 190-193.

  3. Farsani SM, Dijkman R, Jebbink MF, Goossens H, Ieven M, Deijs M et al. The first complete genome sequences of clinical isolates of human coronavirus 229E. Virus Genes. 2012; 45: 433-439.

  4. Tyrrell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect. 1993; 111: 143-156.

  5. Monto AS. Medical reviews. Coronaviruses. Yale J Biol Med. 1974; 47: 234-251.

  6. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016; 24: 490-502.

  7. Van der Hoek L, Pyrc K, Berkhout B. Human coronavirus NL63, a new respiratory virus. FEMS Microbiol Rev. 2006; 30: 760-773.

  8. Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA. 2004; 101: 6212-6216.

  9. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis. 2005; 191: 492-498.

  10. Abdul-Rasool S, Fielding BC. Understanding human coronavirus HCoV-NL63. Open Virol J. 2010; 4: 76-84.

  11. Quiles MJA, Aragon DV, Monsalvo HM, Gomez DM. Non-pneumococcal bacterial pneumonias (II). Respiratory infections by Mycoplasma and Chlamydia. Viral pneumonias. Medicine (Madr). 2018; 12: 3186-3197.

  12. McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA. 1967; 57: 933-940.

  13. Poon LL, Chu DK, Chan KH, Wong OK, Ellis TM, Leung YH et al. Identification of a novel coronavirus in bats. J Virol. 2005; 79: 2001-2009.

  14. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009; 7: 439-450.

  15. Tu C, Crameri G, Kong X, Chen J, Sun Y, Yu M et al. Antibodies to SARS coronavirus in civets. Emerg Infect Dis. 2004; 10: 2244-2248.

  16. Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol. 2005; 79: 11892-11900.

  17. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9: 221-236.

  18. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005; 79: 884-895.

  19. Woo PC, Lau SK, Yip CC, Huang Y, Yuen KY. More and more coronaviruses: human coronavirus HKU1. Viruses. 2009; 1: 57-71.

  20. Woo PC, Lau SK, Tsoi HW, Huang Y, Poon RW, Chu CM et al. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis. 2005; 192: 1898-1907.

  21. Lau SK, Woo PC, Yip CC, Tse H, Tsoi HW, Cheng VC et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol. 2006; 44: 2063-2071.

  22. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010; 48: 2940-2947.

  23. Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013; 13: 745-751.

  24. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367: 1814-1820.

  25. Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013; 13: 859-866.

  26. Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015; 28: 465-522.

  27. Samara EM, Abdoun KA. Concerns about misinterpretation of recent scientific data implicating dromedary camels in epidemiology of Middle East respiratory syndrome (MERS). mBio. 2014; 5: e01430-14.

  28. WHO. Coronavirus causante del síndrome respiratorio de Oriente Medio (MERS-CoV)-Reino de la Arabia Saudita. 2020.

  29. Jiang S, Shi Z, Shu Y, Song J, Gao GF, Tan W et al. A distinct name is needed for the new coronavirus. Lancet. 2020; 395: 949.

  30. Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5: 536-544.

  31. OMS. Declaración del Director General de la OMS relativa a la reunión del Comité de Emergencia del RSI sobre nuevos coronavirus.

  32. Martínez BM. Protocolo de bioseguridad y biocustodia para el manejo de pacientes durante la toma de muestras de casos probables por enfermedad por 2019-NCOV 2020.

  33. WHO. World Health Organization. Novel coronavirus. 2020.

  34. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270-273.

  35. Yoshimoto FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020; 39: 198-216.

  36. Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells. 2020; 9 (5): 1267.

  37. Liu WJ, Bi Y, Wang D, Gao GF. On the centenary of the spanish flu: being prepared for the next pandemic. Virol Sin. 2018; 33: 463-466.

  38. Enfermedades CpeCylPd. Pandemia de 1957-1958 (virus H2N2). 2020.

  39. Enfermedades CpeCylPd. Pandemia de 1968 (virus H3N2). 2020.

  40. Kreuder Johnson C, Hitchens PL, Smiley Evans T, Goldstein T, Thomas K, Clements A et al. Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci Rep. 2015; 5: 14830.

  41. Holmes EC, Dudas G, Rambaut A, Andersen KG. The evolution of Ebola virus: Insights from the 2013-2016 epidemic. Nature. 2016; 538: 193-200.




2020     |     www.medigraphic.com